美国烧伤外科医生德尔菲小组:创新烧伤产品减少自体移植的临床意义阈值
第二轮以≥70%同意为共识标准,7项声明中5项达成共识,包括在成人深二度和全层烧伤三种治疗场景中,减少供皮量达到特定阈值具有临床意义。
要点
- 减少供皮量可改善严重烧伤患者预后并降低供区并发症。
- 共识定义临床意义阈值为基于三种治疗场景的供皮减少量。
- 满足阈值的创新细胞和/或组织产品有望改善严重烧伤结局。
核心结论
- 创新细胞和/或组织产品若能使供皮减少量达到所确定的阈值,有潜力显著改善严重烧伤患者的结局。
主要发现
- 第二轮中,7项共识声明有5项达到共识,共识定义为≥70%同意。
- 所有小组成员同意,临床意义地减少所需供皮量将促进创面管理并降低患者供区并发症。
- 基于三种治疗场景,成人深二度和全层烧伤的供皮减少量达到临床意义阈值方面达成共识。
关键数值与推荐
- 共识标准为≥70%同意。
- 在成人深二度和全层烧伤的三种治疗场景中,就自体移植所需供皮量的临床意义减少达成共识。
临床怎么用
- 临床可参考该共识阈值评估创新细胞和/或组织产品减少供皮量的临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reducing the amount of donor skin needed for definitive wound closure can improve outcomes in patients with severe burns. This Delphi Consensus Panel (DCP) aimed to achieve expert consensus on the percentage reduction in donor skin for autograft that constitutes a clinically meaningful benefit. A two-round DCP of fifteen US burn surgeons was conducted via a web-based survey platform. Fourteen panelists (93.3%) completed both rounds. In Round 2, consensus, defined as ≥70% agreement, was achieved for five of the seven consensus statements. All panelists agreed that a clinically meaningful reduction in the amount of donor skin required would facilitate wound management and decrease donor site morbidity experienced by patients. Furthermore, based on three treatment scenarios, consensus was achieved for a clinically meaningful reduction in the amount of donor skin required for autograft for the adult population in deep partial-thickness and full-thickness burns. Findings from this DCP indicate that an innovative cellular and/or tissue product that would reduce the needed amount of donor skin, by the identified thresholds, has the potential to improve the outcomes for patients with severe burn injuries in a meaningful way.
引用
- Gibson ALF, Smiell J, Yu TC, et al. Determining clinically meaningful thresholds for innovative burn care products to reduce autograft: A US burn surgeon Delphi panel. Burns. 2020. PMID: 33303264. doi:10.1016/j.burns.2020.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。